156 related articles for article (PubMed ID: 35738673)
1. Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated Pituitary Macroadenoma?
Alali AA; Hanagandi PB; Maralani PJ
AJNR Am J Neuroradiol; 2022 Jul; 43(7):1024-1028. PubMed ID: 35738673
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumor residuals in pituitary adenoma surgery with intraoperative MRI: do we need gadolinium?
Gohla G; Bender B; Tatagiba M; Honegger J; Ernemann U; Roder C
Neurosurg Rev; 2020 Dec; 43(6):1623-1629. PubMed ID: 31728847
[TBL] [Abstract][Full Text] [Related]
3. Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas?
Boto J; Guatta R; Fitsiori A; Hofmeister J; Meling TR; Vargas MI
AJNR Am J Neuroradiol; 2021 Aug; 42(8):1421-1428. PubMed ID: 34117017
[TBL] [Abstract][Full Text] [Related]
4. MRI 3D SPACE T2WI for Pituitary Adenoma Cavernous Sinus Invasion Diagnosis.
Chen Y; Cai S; Li X; Zhang J; Wei L; Wang S
World Neurosurg; 2024 May; 185():e1257-e1267. PubMed ID: 38514027
[TBL] [Abstract][Full Text] [Related]
5. The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
Nakamura T; Schörner W; Bittner RC; Felix R
Neuroradiology; 1988; 30(6):481-6. PubMed ID: 3226534
[TBL] [Abstract][Full Text] [Related]
6. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
[TBL] [Abstract][Full Text] [Related]
7. Application of magnetic resonance 3D-SPACE sequence combined image fusion technique in preoperative evaluation of pituitary macroadenoma.
Nie J; Meng L; Li Z; Zhou G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):980-987. PubMed ID: 33053542
[TBL] [Abstract][Full Text] [Related]
8. Preoperative depiction of cavernous sinus invasion by pituitary macroadenoma using three-dimensional anisotropy contrast periodically rotated overlapping parallel lines with enhanced reconstruction imaging on a 3-tesla system.
Yoneoka Y; Watanabe N; Matsuzawa H; Tsumanuma I; Ueki S; Nakada T; Fujii Y
J Neurosurg; 2008 Jan; 108(1):37-41. PubMed ID: 18173308
[TBL] [Abstract][Full Text] [Related]
9. Gd-DTPA-enhanced MR imaging of pituitary adenomas.
Newton DR; Dillon WP; Norman D; Newton TH; Wilson CB
AJNR Am J Neuroradiol; 1989; 10(5):949-54. PubMed ID: 2505539
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.
Davis PC; Hoffman JC; Malko JA; Tindall GT; Takei Y; Avruch L; Braun IF
AJNR Am J Neuroradiol; 1987; 8(5):817-23. PubMed ID: 3118674
[TBL] [Abstract][Full Text] [Related]
11. Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images.
Gao R; Isoda H; Tanaka T; Inagawa S; Takeda H; Takehara Y; Isogai S; Sakahara H
Eur J Radiol; 2001 Sep; 39(3):139-46. PubMed ID: 11566239
[TBL] [Abstract][Full Text] [Related]
12. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S
J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of macroadenomas.
Mohammad-Zadeh L
Radiol Technol; 1995; 67(1):29-36; quiz 37-8. PubMed ID: 7491407
[TBL] [Abstract][Full Text] [Related]
14. Is systematic Gadolinium injection relevant during MRI follow-up for non-functioning pituitary macroadenomas?
Villemaire A; Adam G; Fayolle H; Roques M; Darcourt J; Caron P; Bonneville F
J Neuroradiol; 2023 Feb; 50(1):3-8. PubMed ID: 36055429
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients.
Davis PC; Gokhale KA; Joseph GJ; Peterman SB; Adams DA; Tindall GT; Hudgins PA; Hoffman JC
Radiology; 1991 Sep; 180(3):779-84. PubMed ID: 1871293
[TBL] [Abstract][Full Text] [Related]
16. Ectopic posterior pituitary high signal in preoperative and postoperative macroadenomas: dynamic MR imaging.
Takahashi T; Miki Y; Takahashi JA; Kanagaki M; Yamamoto A; Fushimi Y; Okada T; Haque TL; Hashimoto N; Konishi J; Togashi K
Eur J Radiol; 2005 Jul; 55(1):84-91. PubMed ID: 15950103
[TBL] [Abstract][Full Text] [Related]
17. Pituitary microadenomas: diagnosis with dynamic serial CT, conventional CT and T1-weighted MR imaging before and after injection of gadolinium.
Stadnik T; Spruyt D; van Binst A; Luypaert R; d'Haens J; Osteaux M
Eur J Radiol; 1994 Aug; 18(3):191-8. PubMed ID: 7957289
[TBL] [Abstract][Full Text] [Related]
18. Gd-DTPA-enhanced MR imaging of pituitary macroadenomas.
Lundin P; Bergström K
Acta Radiol; 1992 Jul; 33(4):323-32. PubMed ID: 1633042
[TBL] [Abstract][Full Text] [Related]
19. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
Ko CC; Chen TY; Lim SW; Kuo YT; Wu TC; Chen JH
J Neurosurg; 2019 Feb; 132(2):351-359. PubMed ID: 30717054
[TBL] [Abstract][Full Text] [Related]
20. Peritumoral cysts associated with pituitary macroadenoma.
Herde RF; Hoang N; Tran DK; Couldwell G; Couldwell WT; Osborn AG
J Neurosurg; 2015 Sep; 123(3):789-93. PubMed ID: 26140485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
